Evidence map›Paper›PMID 42379166›Full record

ArticleCell2026

Multiscale integration of tissue and chromatin context converts cell heterogeneity into stable intestinal patterning.

Cornelia Schwayer, Silvia Barbiero, David B Brückner, Koen C Oost, Clara Baader, Nicole A Repina, Jinse Kim, Oscar E Diaz, Isa Uccelli, Laura Capolupo and 15 more

Abstract read
In one paragraph

Article in Cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Cornelia SchwayerFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland; ETH Zürich, Department for Biosystems Science and Engineering (D-BSSE), 4056 Basel, Switzerland.
Silvia BarbieroFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland; ETH Zürich, Department for Biosystems Science and Engineering (D-BSSE), 4056 Basel, Switzerland; University of Basel, 4001 Basel, Switzerland.
David B BrücknerInstitute of Science and Technology Austria, 3400 Klosterneuburg, Austria; Biozentrum, University of Basel, 4056 Basel, Switzerland; Department of Physics, University of Basel, 4056 Basel, Switzerland.
Koen C OostFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland.
Clara BaaderFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland; University of Basel, 4001 Basel, Switzerland.
Nicole A RepinaFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland.
Jinse KimDepartment of Metabolic Biology and Nutrition, UC Berkeley, Berkeley, CA 94720, USA.
Oscar E DiazThe Francis Crick Institute, London NW1 1AT, UK.
Isa UccelliFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland.
Laura CapolupoETH Zürich, Department for Biosystems Science and Engineering (D-BSSE), 4056 Basel, Switzerland.
Ludivine Challet MeylanETH Zürich, Department for Biosystems Science and Engineering (D-BSSE), 4056 Basel, Switzerland.
Veronique KalckFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland.
Franziska MoosFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland.
Simon SuppingerFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland; ETH Zürich, Department for Biosystems Science and Engineering (D-BSSE), 4056 Basel, Switzerland; University of Basel, 4001 Basel, Switzerland.
Qiutan YangFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland.
Jakob SchnablFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland.
Umut KilikBiozentrum, University of Basel, 4056 Basel, Switzerland; Institute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center, 4070 Basel, Switzerland.
Matthieu BourdonFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland.
J Gray CampBiozentrum, University of Basel, 4056 Basel, Switzerland; Institute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center, 4070 Basel, Switzerland.
Brigitta StockingerThe Francis Crick Institute, London NW1 1AT, UK.
Alessandra FerrariDepartment of Metabolic Biology and Nutrition, UC Berkeley, Berkeley, CA 94720, USA.
Marc BühlerFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland; University of Basel, 4001 Basel, Switzerland.
Michael B StadlerFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland; University of Basel, 4001 Basel, Switzerland; Swiss Institute of Bioinformatics, 4056 Basel, Switzerland.
Edouard HannezoInstitute of Science and Technology Austria, 3400 Klosterneuburg, Austria. Electronic address: edouard.hannezo@ist.ac.at.
Prisca LiberaliFriedrich Miescher Institute for Biomedical Research, 4056 Basel, Switzerland; ETH Zürich, Department for Biosystems Science and Engineering (D-BSSE), 4056 Basel, Switzerland; University of Basel, 4001 Basel, Switzerland. Electronic address: prisca.liberali@fmi.ch.

Funding

Wellcome Trust FC001159
6 · The paper itself

Abstract

Tissue regeneration requires de novo patterning, which has been proposed to be facilitated by cellular heterogeneity. Yet how such heterogeneities are integrated with the mechanochemical state of the tissue and stabilized at the chromatin level into stable, spatially organized fates remains poorly understood. Using in vivo mouse intestinal regeneration models and organoids, we identify a critical density regime that produces a permissive window for heterogeneity in the mechanosensor Yes-associated protein 1 (YAP1). We show that YAP1 heterogeneity is coupled to lineage-biased chromatin accessibility and is decoded through FOXA1, which integrates the permissive chromatin state to Delta-Notch supracellular feedback and lineage commitment. This circuit generates fate bistability and preserves a memory of transient YAP1 activity, thereby maintaining spatial patterning as tissues return to homeostasis after injury. Together, our findings establish a multiscale framework in which tissue-scale mechanics tune single-cell competence and, through FOXA1-mediated bistability, convert transient heterogeneity into stable and self-organized tissue architecture.

Indexed as

Adaptor Proteins, Signal TransducingChromatinIntestinesAnimalsCell Cycle ProteinsCell LineageHepatocyte Nuclear Factor 3-alphaMiceOrganoidsRegenerationYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingCell Cycle ProteinsChromatinFoxa1 protein, mouseHepatocyte Nuclear Factor 3-alphaYap1 protein, mouseYAP-Signaling Proteinsepigenetic competenceheterogeneityimage-based phenotypingintestinal regenerationmechanicsmodelingmultiscale integrationorganoidstissue patterningYap1

Identifiers

PMID42379166
PMCPMC13502998

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.